Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Life Intelligence Consortium
Osaka, Osaka Prefecture, Japan
- Ownership
- Private
- Development stage
- Other
01
Overview
Life Intelligence Consortium (LINC) is a Japanese industry–academia consortium that advances applications of AI, big data, and IoT in life sciences, including collaborative AI drug discovery infrastructure; it does not itself develop therapeutic products.[2][4][6]
- Industry
- Drug Discovery Services
02
Partnerships
Elix[2][4][5]Japan Agency for Medical Research and Development (AMED) via DAIIA project participation context[2][4][5]Multiple Japanese pharmaceutical companies participating in DAIIA (around 16–17 companies, not individually listed in the sources)[2][4][5]
Beyond the preview
Go deeper on Life Intelligence Consortium.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Life Intelligence Consortium.